Time‐dependent lipid profile inversely associates with mortality in hemodialysis patients – independent of inflammation/malnutrition
暂无分享,去创建一个
F. Kronenberg | D. Wheeler | C. Lamina | J. Floege | K. Eckardt | M. Froissart | P. Stenvinkel | T. Ebert | J. Fotheringham | A. R. Qureshi
[1] P. Stenvinkel,et al. Inflammation and Premature Ageing in Chronic Kidney Disease , 2020, Toxins.
[2] L. G. Vu,et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2020, The Lancet.
[3] C. Zoccali,et al. Lipid management in patients with chronic kidney disease , 2018, Nature Reviews Nephrology.
[4] Yuedong Wang,et al. Lipid levels are inversely associated with infectious and all-cause mortality: international MONDO study results , 2018, Journal of Lipid Research.
[5] Connie M. Rhee,et al. Inverse Association Between Serum Non–High‐Density Lipoprotein Cholesterol Levels and Mortality in Patients Undergoing Incident Hemodialysis , 2018, Journal of the American Heart Association.
[6] Jennifer G. Robinson,et al. Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering: A Systematic Review and Meta-analysis , 2018, JAMA.
[7] M. Landray,et al. Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation , 2017, Kidney international.
[8] F. Kronenberg,et al. High cardiovascular event rates occur within the first weeks of starting hemodialysis , 2015, Kidney international.
[9] Florian Kronenberg,et al. Development and validation of a predictive mortality risk score from a European hemodialysis cohort , 2015, Kidney international.
[10] K. Kalantar-Zadeh,et al. Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[11] M. Tonelli,et al. KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient. , 2014, Kidney international.
[12] Yu-ming Chen,et al. Effects of blood triglycerides on cardiovascular and all-cause mortality: a systematic review and meta-analysis of 61 prospective studies , 2013, Lipids in Health and Disease.
[13] D. Fliser,et al. Uraemic dyslipidaemia revisited: role of high-density lipoprotein. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[14] M. Landray,et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial , 2011, The Lancet.
[15] Patrick Royston,et al. Multiple imputation using chained equations: Issues and guidance for practice , 2011, Statistics in medicine.
[16] Florian Kronenberg,et al. An Epidemiological Study of Hemodialysis Patients Based on the European Fresenius Medical Care Hemodialysis Network: Results of the ARO Study , 2010, Nephron Clinical Practice.
[17] B. Astor,et al. Malnutrition-inflammation modifies the relationship of cholesterol with cardiovascular disease. , 2010, Journal of the American Society of Nephrology : JASN.
[18] M. Woodward,et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis , 2010, The Lancet.
[19] R. Shamburek,et al. Seven direct methods for measuring HDL and LDL cholesterol compared with ultracentrifugation reference measurement procedures. , 2010, Clinical chemistry.
[20] B. Rutkowski,et al. Temporal discrepancies in the association between the apoB/apoA‐I ratio and mortality in incident dialysis patients , 2009, Journal of internal medicine.
[21] Gert Mayer,et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. , 2009, The New England journal of medicine.
[22] C. Wanner,et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. , 2008, Kidney international.
[23] R. Collins,et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths , 2007, The Lancet.
[24] M. Landray,et al. CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: Misleading Associations between Cholesterol and Vascular Outcomes in Dialysis Patients: The Need for Randomized Trials , 2007, Seminars in dialysis.
[25] Ja‐Liang Lin,et al. Fasting glucose levels in predicting 1-year all-cause mortality in patients who do not have diabetes and are on maintenance hemodialysis. , 2007, Journal of the American Society of Nephrology : JASN.
[26] S. Anker,et al. Risk factor paradox in wasting diseases , 2007, Current opinion in clinical nutrition and metabolic care.
[27] K. Kalantar-Zadeh,et al. Association between serum lipids and survival in hemodialysis patients and impact of race. , 2007, Journal of the American Society of Nephrology : JASN.
[28] K. Kalantar-Zadeh,et al. Inverse association between lipid levels and mortality in men with chronic kidney disease who are not yet on dialysis: effects of case mix and the malnutrition-inflammation-cachexia syndrome. , 2007, Journal of the American Society of Nephrology : JASN.
[29] A. Kazory,et al. Impact of malnutrition-inflammation on the association between homocysteine and mortality. , 2006, Kidney international.
[30] W. März,et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. , 2005, The New England journal of medicine.
[31] Charles E McCulloch,et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.
[32] P. Couture,et al. Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population. , 2004, Clinical biochemistry.
[33] N. Powe,et al. Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. , 2004, JAMA.
[34] H Steil,et al. EuCliD® – A Medical Registry , 2004, Methods of Information in Medicine.
[35] J. Frohlich,et al. Triglycerides and small dense LDL: the twin Achilles heels of the Friedewald formula. , 2003, Clinical biochemistry.
[36] K. Iseki,et al. Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients. , 2002, Kidney international.
[37] S. Anker,et al. The endotoxin-lipoprotein hypothesis , 2000, The Lancet.
[38] K. Feingold,et al. Lipoproteins: Are they important components of host defense? , 1997, Hepatology.
[39] David A. Schoenfeld,et al. Partial residuals for the proportional hazards regression model , 1982 .